The superagent's "Iceberg" nickname suddenly seems outdated -- with $200 million in funds, a palpable exuberance and a new agency, Resolution, whose moves have rivals riveted. By Stephen Galloway Jeff ...
In November 2013, more than 100 patients with cancer - including pancreatic, breast, liver and brain tumours - embarked on clinical trials involving BPM 31510, a drug discovered by an algorithm.
A new brain cancer drug developed with the help of artificial intelligence is to begin first-in-man trials. BERG is kicking off a phase 1/2 trial of BPM 31510-IV investigating its safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results